Hypertension, Pulmonary: all 1,119 studies

Page 11 of 12. Open to participants first (236), then studies with results posted, then the rest; newest registration first within each.

• Water- and Salt-homeostasis in Healthy Humans, and in Patients With Heart- or Lung DiseaseStatus unknownNCT00830726
• Biomarkers in Pulmonary Hypertension Associated to Interstitial Lung DiseaseCompletedNCT00820729
• Safety and Efficacy of Bosentan in Patients With Diastolic Heart Failure and Secondary Pulmonary HypertensionCompletedNCT00820352Phase 3
• Milrinone Inhaled in Cardiac SurgeryCompletedNCT00819377Phase 2
• Body Volume Regulation in Pulmonary Arterial Hypertension With Right Ventricular FailureWithdrawnNCT00811486Not applicable
• Does Sildenafil Increase Exercise Performance in Air Pollution?CompletedNCT00808912Not applicable
• Sildenafil IV Bolus StudyCompletedNCT00800592Phase 1
• Study Evaluating the Addition of Sildenafil to Bosentan Therapy in Pulmonary Arterial HypertensionWithdrawnNCT00780728Phase 3
• FREEDOM DR: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Phosphodiesterase-5 (PDE-5) Inhibitor or as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)WithdrawnNCT00760916Phase 3
• Lung Protective Ventilation in Pulmonary Thromboendarterectomy (PTE) PatientsCompletedNCT00747045Not applicable
• The Effect of Blood Flow in the Maturing Arteriovenous Access for Hemodialysis on the Development of Pulmonary Hypertension.CompletedNCT00739375Phase 1
• Sildenafil for Chronic Obstructive Pulmonary Disease (COPD) Associated Pulmonary HypertensionWithdrawnNCT00730067Phase 4
• Reversible Secondary Myelofibrosis or Clonal Myeloproliferative DisorderTerminatedNCT00722254
• The Efficacy and Safety of Vardenafil in the Treatment of Pulmonary Arterial HypertensionCompletedNCT00718952Phase 3
• Pharmacokinetics and Pharmacdynamics of SildenafilTerminatedNCT00718185
• Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc)TerminatedNCT00706082
• Impact of Multiple Doses of BAY63-2521 on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Patients With Interstitial Lung Disease (ILD) Associated Pulmonary Hypertension (PH)CompletedNCT00694850Phase 2
• Interaction Study in Patients With Pulmonary Hypertension and Stable Treatment of Sildenafil 20 mg TIDCompletedNCT00680654Phase 1
• An Observational Study For AmbrisentanCompletedNCT00679224
• Effects of Bosentan on Respiratory MechanicsTerminatedNCT00679068Phase 4
• Aerobic Exercise in Patients With Pulmonary HypertensionCompletedNCT00678821Phase 2
• An Open-Label Study to Evaluate the Safety and Efficacy of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary DiseaseTerminatedNCT00677872Phase 2
• Effect of Endothelin-1 Receptor Blockade on Circulating Endothelial Microparticles Levels in Patients With Pulmonary HypertensionCompletedNCT00675051
• Identification of Criteria of the Success of the Endarterectomy in Chronic Pulmonary Post Embolic HypertensionCompletedNCT00657722Not applicable
• A Study to Assess the Efficacy and Safety of 20, 40, and 80mg of Sildenafil Three Times a Day in the Treatment of Pulmonary Arterial HypertensionCompletedNCT00644605Phase 3
• Bosentan in Pulmonary Hypertension in Interstitial Lung Disease Treatment StudyStatus unknownNCT00637065Phase 4
• The Study Of CT Scans and Echo Parameters in Patients With PAHCompletedNCT00625963
• Pulmonary Hypertension Secondary to Idiopathic Pulmonary Fibrosis And Treatment With SildenafilWithdrawnNCT00625079Phase 4
• Circulatory Changes During Venovenous (VV)- and Venoarterial (VA) Extracorporeal Membrane Oxygenation (ECMO)Status unknownNCT00622492
• Correlation OF Hemodynamics in Pulmonary Hypertension With Perfusion Lung ScansCompletedNCT00621075
• Atorvastatin in Pulmonary HypertensionCompletedNCT00615823Phase 2
• Prevalence of Pulmonary Hypertension in COPD PatientsCompletedNCT00614900
• Inhaled PGE1 in Neonatal Hypoxemic Respiratory FailureWithdrawnNCT00598429Phase 2
• Pulmonary Artery Remodelling With BosentanCompletedNCT00595049Phase 4
• Pharmacogenomics in Pulmonary Arterial HypertensionWithdrawnNCT00593905
• Double Blind, Randomized Trial of Bosentan for Sarcoidosis Associated Pulmonary HypertensionCompletedNCT00581607Phase 2/3
• Study of Dehydroepiandrosterone (DHEA) in Respiratory Pulmonary Hypertension in AdultsCompletedNCT00581087Phase 3
• Magnetic Resonance Imaging in the Diagnosis of Pulmonary HypertensionCompletedNCT00575692
• Sleep Disturbances and Pulmonary Artery/Aorta Diameter in Scleroderma PatientCompletedNCT00566137
• Iloprost in Gas Exchange/Pulm Mechanics in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00561223Not applicable
• Susceptibility to High Altitude Pulmonary Edema in Subjects With Increased Hypoxic Pulmonary VasoconstrictionCompletedNCT00559442Not applicable
• Simvatstatin Used to Treat Pulmonary HypertensionStatus unknownNCT00538044Phase 1
• Role of Nitric Oxide in MalariaCompletedNCT00527163
• Losartan Therapy in Pulmonary HypertensionCompletedNCT00519870Phase 3
• Effect of Tadalafil in Chronic Obstructive Lung Disease Patients Suffering From Secondary Pulmonary HypertensionWithdrawnNCT00506701Not applicable
• Pulmonary Hypertension, Hypoxia and Sickle Cell DiseaseCompletedNCT00495638
• Sildenafil Effects on Pulmonary Haemodynamics and Gas Exchange in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00491803Phase 4
• Exercise and Respiratory Therapy in Patients With Rheumatoid Arthritis / Collagenosis and Pulmonary HypertensionStatus unknownNCT00491309Not applicable
• Pulmonary Hypertension in Trisomy 21 PatientsCompletedNCT00478296
• Latent Pulmonary Hypertension (PH) in Chronic Thromboembolic Pulmonary Hypertension (CTEPH )After Endarterectomy and Influence of Exercise and Respiratory TherapyStatus unknownNCT00477724Not applicable
• Pulmonary Hypertension: Assessment of Cell TherapyCompletedNCT00469027Phase 1
• Vasoactive Intestinal Peptide in COPDCompletedNCT00464932
• Study of the Efficacy and Safety of Tezosentan in Patients With Pre-operative Pulmonary Hypertension, Due to Left Heart Disease, Undergoing Open Heart SurgeryTerminatedNCT00458276Phase 3
• Transitioning To IV Remodulin From Ventavis in Patients With PAH: Safety, Efficacy and Treatment SatisfactionTerminatedNCT00458042Phase 4
• An Open Multiple Dose Titration Study In Patients With Pulmonary HypertensionCompletedNCT00454558Phase 2
• Changes in Eye Pressure and Anterior Chamber Depth With Oral Endothelin Antagonist TherapyCompletedNCT00452283
• N-Terminal Pro-brain Natriuretic Peptide Hormone and Persistent Pulmonary HypertensionTerminatedNCT00443859
• Trial of Iloprost in Pulmonary Hypertension Secondary to Pulmonary FibrosisStatus unknownNCT00439543Phase 2/3
• Evaluation of the Prevalence of Pulmonary Hypertension in Adult Patients With Sickle Cell DiseaseStatus unknownNCT00434902
• Effect of Bosentan on Exercise Capacity at High AltitudeCompletedNCT00432978Phase 1
• Aerosolized Randomized Iloprost Study II (AIR - II) Long-Term Safety, Tolerability, and Clinical Effects of Iloprost Inhalation in Patients With Primary or Secondary Pulmonary HypertensionCompletedNCT00414687Phase 2
• Inhaled Iloprost for the Treatment of Persistent Pulmonary Hypertension in the Term and Near Term Infants.TerminatedNCT00409526Phase 4
• Inhaled Iloprost for Sarcoidosis-associated Pulmonary HypertensionCompletedNCT00403650Phase 4
• Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma PatientsCompletedNCT00377949
• REVEAL Registry™: Registry to Evaluate Early And Long-term PAH Disease ManagementCompletedNCT00370214
• Pulmonary Hypertension in Patients With Sickle Cell Disease in NigeriaCompletedNCT00367523
• A Study of Patients Having Pulmonary Hypertension Associated With Sickle Cell Disease and Completing an ASSET StudyTerminatedNCT00360087Phase 3
• Sildenafil to Increase Exercise Capacity in Individuals With Idiopathic Pulmonary Fibrosis and Pulmonary HypertensionCompletedNCT00352482Phase 2
• Cardiopulmonary Function Assessment and NO-Based Therapies for Patients With Hemolysis-Associated Pulmonary HypertensionCompletedNCT00352430Phase 1
• Gene Mutations in Secondary Pulmonary HypertensionStatus unknownNCT00348803
• Safety and Effectiveness of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary DiseaseCompletedNCT00345774Phase 2
• Intravenous L-Citrulline to Treat Children Undergoing Heart Bypass SurgeryCompletedNCT00335244Phase 3
• Does Oral Sildenafil (Viagra) Decrease Mean Pulmonary Artery Pressure After Cardiac Surgery?CompletedNCT00334490Phase 2
• Sildenafil to Treat HIV-Associated Pulmonary HypertensionTerminatedNCT00327080Phase 1
• Dose Determination Safety and Activity Study of Inhaled NX1011 to Treat Pulmonary Arterial HypertensionWithdrawnNCT00323024Phase 2
• Inhaled Prostacyclin for Adult Respiratory Distress Syndrome (ARDS) and Pulmonary HypertensionCompletedNCT00314548Not applicable
• Bosentan Effects in Inoperable Forms of Chronic Thromboembolic Pulmonary HypertensionCompletedNCT00313222Phase 3
• Efficacy and Safety of Bosentan in Sickle Cell Disease (SCD) Patients Diagnosed With Pulmonary Hypertension (PH)TerminatedNCT00313196Phase 3
• Efficacy and Safety of Bosentan in Sickle Cell Disease (SCD) Patients With Pulmonary Arterial Hypertension (PAH)TerminatedNCT00310830Phase 3
• Prevention of High Altitude Pulmonary EdemaCompletedNCT00274430Phase 1/2
• Hydroxyurea and Erythropoietin to Treat Sickle Cell AnemiaCompletedNCT00270478Phase 1
• Observation of Patients With Primary Pulmonary Hypertension Receiving Prescribed Ventavis Inhalation Therapy Regarding Safety and Efficacy for up to 4 YearsCompletedNCT00250640
• Spironolactone Combined With Captopril and Carvedilol for the Treatment of Pulmonary Arterial HypertensionCompletedNCT00240656Phase 1
• Iloprost-Study: Comparison of Nitric Oxide to Iloprost (Ventavis) for Treatment of Pulmonary Hypertension in Children After Cardiopulmonary Bypass SurgeryCompletedNCT00235521Not applicable
• Treatment of Elevated Arterial Pulmonary Pressure With Inhaled IloprostWithdrawnNCT00216931Not applicable
• Natrecor for Pulmonary Hypertension in Lung TransplantsCompletedNCT00205426Phase 4
• Serotonin Transporter Inhibitor Escitalopram in Pulmonary HypertensionCompletedNCT00190333Phase 3
• Safety Follow-up Study of Inhaled Iloprost in Patients With Pulmonary HypertensionCompletedNCT00185315Phase 3
• Genetic Research of Bone Morphogenetic Protein Receptor-II Gene in Taiwanese Patient With Primary Pulmonary HypertensionStatus unknownNCT00173537Not applicable
• Study to Assess the Longterm Safety of Sildenafil Citrate in Patients With Pulmonary Arterial HypertensionCompletedNCT00159887Phase 3
• Efficacy of Type-5 Phosphodiesterase Inhibitors in Primary and Secondary Pulmonary HypertensionWithdrawnNCT00155714Not applicable
• Sildenafil and Pulmonary Artery PressureTerminatedNCT00145938Phase 2
• NO Need to Ventilate: A Trial of Non-invasive Inhaled Nitric Oxide in Persistent Pulmonary Hypertension of the NewbornCompletedNCT00139217Not applicable
• PHIRST-1: Tadalafil in the Treatment of Pulmonary Arterial HypertensionCompletedNCT00125918Phase 3
• Heart Disease in Sickle Cell AnemiaCompletedNCT00113152
• Inhaled Iloprost in Adults With Abnormal Pulmonary Pressure and Associated With Idiopathic Pulmonary FibrosisCompletedNCT00109681Phase 2
• A Study of Aspirin and Clopidogrel in Patients With Idiopathic Pulmonary Arterial HypertensionCompletedNCT00105209Phase 2
• Efficacy and Safety of Oral Bosentan in Pulmonary Arterial Hypertension Class IICompletedNCT00091715Phase 3
• ARIES - Ambrisentan in Patients With Moderate to Severe Pulmonary Arterial Hypertension (PAH)CompletedNCT00091598Phase 3
• Genetic and Environmental Characteristics of Primary Pulmonary HypertensionCompletedNCT00091546

← Hypertension, Pulmonary overview